Developed by diabetics for diabetics. DiabetesPlus lets you administer your readings on your device and saves time by enabling you to send the data directly to your doctor.

In order to ensure that patients who really need their opioids get them, the state of Florida now mandates that every pharmacist must have a CE on Controlled Medication Dispensing. Seven years ago, Florida dispensed 10 times the amount of opioids as the rest of the country added together. However, …

A patient, 48 years of age, female, type 2 diabetes and obese, was referred to me for diabetes and weight management. Her first visit was 8 a.m., after fasting for 10 hours. Her A1c was 7.4%, BMI 37, BP 164/92, HR 92. The previous hcp had recorded she was recommended a low carb diet and the following medications: Metformin, 1,000mg twice daily; Byetta 10mcg sq twice daily. It was also written that she was non-compliant.

In part 3 of this Exclusive Interview, Blandine Lacroix talks about applying motivational interviewing in the patient/provider conversation around diabetes.

In this week's Homerun Slides, recognizing the role of Glycocalyx in microvascular and macrovascular dysfunction.

The liver regulates nutrient supply to the entire body. Antoine Lavoisier first scientifically disputed the concept of vitalism by proving that the combustion of material in the blood formed the basis of life and mechanical work by muscle. He suggested that these nutrients were not only absorbed by digestion but that liver played an important anabolic role in maintaining life.

For many of our patients, the desire to exercise is often overwhelmed by the pain associated with the activity. Other patients who are reluctant to exercise in the first place will use any pain as an excuse to stop. Interestingly, much of the pain they complain of could be eliminated …

Type 1 beta cells succumb to autoimmunity, leaving significantly reduced beta-cell mass and lifelong dependence on insulin replacement therapy, while type 2 beta cells fail to secrete sufficient insulin to overcome prevailing insulin resistance.

In a new international clinical trial, it was shown that the drug liraglutide 3.0 mg may reduce diabetes risk by 80% in individuals with obesity and prediabetes.

Insulin resistance associated with high blood pressure and other risk factors.